Hercules Capital Inc  

(Public, NYSE:HTGC)   Watch this stock  
Find more results for NASDAQ:HTGC
12.11
-0.10 (-0.82%)
Jun 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 11.98 - 12.22
52 week 9.88 - 12.70
Open 12.00
Vol / Avg. 202,925.00/205,355.00
Mkt cap 884.78M
P/E 25.42
Div/yield 0.31/10.24
EPS 0.48
Shares 73.66M
Beta 0.97
Inst. own 41%
Aug 4, 2016
Q2 2016 Hercules Capital Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 7, 2016
Hercules Capital Inc Annual Shareholders Meeting - 12:00PM EDT - Add to calendar
Jul 6, 2016
Hercules Technology Growth Capital Inc Annual Shareholders Meeting (Estimated) - 9:00AM EDT - Add to calendar
May 5, 2016
Q1 2016 Hercules Capital Inc Earnings Call - Webcast
May 5, 2016
Q1 2016 Hercules Capital Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 36.71% 27.31%
Operating margin 51.61% 46.78%
EBITD margin - 46.90%
Return on average assets 4.32% 3.27%
Return on average equity 7.77% 6.02%
Employees 63 -
CDP Score - -

Address

400 Hamilton Ave Ste 310
PALO ALTO, CA 94301-1805
United States - Map
+1-650-2893060 (Phone)
+1-650-4739194 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hercules Capital, Inc., formerly Hercules Technology Growth Capital, Inc., is a specialty finance company. The Company is focused on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences and sustainable and renewable technology industries. The Company is an internally managed, non-diversified, closed-end investment company. The Company focuses its investments in companies active in the technology industry sub-sectors characterized by products or services, including computer software and hardware; networking systems; semiconductors; semiconductor capital equipment; information technology infrastructure or services; Internet consumer and business services; telecommunications; telecommunications equipment, and media. Within the life science sub-sector, the Company focuses on medical devices, bio-pharmaceutical, drug discovery, drug delivery, healthcare services and information systems companies.

Officers and directors

Manuel A. Henriquez Chairman of the Board, President, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark Robert Harris CPA Chief Financial Officer
Age: 45
Bio & Compensation  - Reuters
Scott Bluestein Chief Investment Officer
Age: 36
Bio & Compensation  - Reuters
Melanie Grace Chief Compliance Officer, General Counsel
Age: 46
Bio & Compensation  - Reuters
Andrew Olson Vice President - Finance, Senior Controller
Age: 32
Bio & Compensation  - Reuters
Jennifer McKay Vice President of Human Resources
Bio & Compensation  - Reuters
Allyn C. Woodward Jr. Lead Independent Director
Age: 74
Bio & Compensation  - Reuters
Robert P. Badavas Independent Director
Age: 62
Bio & Compensation  - Reuters
Thomas J. Fallon Independent Director
Age: 54
Bio & Compensation  - Reuters
Rodney A. Ferguson Ph.D., J.D., Independent Director
Age: 54
Bio & Compensation  - Reuters